In the treatment of inflammatory bowel disease, synthetic mucus gels can be used to deliver monoclonal antibodies without inducing broad immunosuppression.

In patients with cystic fibrosis, CMTX-101, an immune-enabling antibody therapy, lowered four inflammatory biomarkers and ...

A trial was about to launch for a vaccine that would ward off the HIV virus. It would be an incredible breakthrough. Then it ...

In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a series of vaccines can coax the immune system to produce powerful antibodies ...

Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...

The team’s research provides compelling evidence for the brain’s influence on physiology. A deeper understanding of this mind ...

Researchers found an association between increased activity in a reward region of the brain—primarily stimulated by hopeful thinking—and heightened levels of protective antibodies after receiving a va ...

According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Medicine , the novel monoclonal antibody linavonkibart demonstrated the ...

UF Health Cancer Institute researchers have discovered a small compound produced naturally by gut bacteria that doubled the ...